BlueSync™ Field Evaluation
The primary goal is to learn how many CareLink quarterly scheduled transmissions are completed within a prescribed time period to assess CareLink scheduled transmission compliance. The evaluation will also assess adoption to remote monitoring, patient perceived benefit of BlueSync™ (how patients interact with the smart device application) and healthcare provider perception of the value of BlueSync™ and satisfaction with BlueSync™ (benefits experienced by clinicians who use BlueSync™).
- Patient will be/has been implanted with an Azure™ or Percepta™, Serena™, Solara™ CRT-P device compatible with BlueSync™ (both new and replacement devices are allowed)
- Patient must own a smart device (smartphone or tablet) that meets system requirements and be willing to use during evaluation period
- Patient must be able to complete the required 12-month follow-up after enrollment